These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9708759)
1. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Neugebauer S; Baba T; Watanabe T Lancet; 1998 Aug; 352(9126):454. PubMed ID: 9708759 [No Abstract] [Full Text] [Related]
2. MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes. Smyth JS; Savage DA; Maxwell AP Lancet; 1999 Apr; 353(9159):1156-7. PubMed ID: 10209988 [No Abstract] [Full Text] [Related]
3. [The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese]. Sun J; Xu Y; Zhu Y Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):529-32. PubMed ID: 11718053 [TBL] [Abstract][Full Text] [Related]
4. Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes? Blüthner M; Brüntgens A; Schmidt S; Strojek K; Grzeszczak W; Ritz E Nephrol Dial Transplant; 1999 Jan; 14(1):56-7. PubMed ID: 10052477 [No Abstract] [Full Text] [Related]
5. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients. Shcherbak NS; Shutskaya ZV; Sheidina AM; Larionova VI; Schwartz EI Mol Genet Metab; 1999 Nov; 68(3):375-8. PubMed ID: 10562465 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus. Rahimi M; Hasanvand A; Rahimi Z; Vaisi-Raygani A; Mozafari H; Rezaei M; Zargooshi J; Najafi F; Shakiba E Clin Biochem; 2010 Nov; 43(16-17):1333-9. PubMed ID: 20800057 [TBL] [Abstract][Full Text] [Related]
7. A common mutation of the methylenetetrahydrofolate reductase gene as a risk factor for diabetic nephropathy. Odawara M; Yamashita K Diabetologia; 1999 May; 42(5):631-2. PubMed ID: 10333059 [No Abstract] [Full Text] [Related]
8. The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. Shpichinetsky V; Raz I; Friedlander Y; Goldschmidt N; Wexler ID; Ben-Yehuda A; Friedman G J Nutr; 2000 Oct; 130(10):2493-7. PubMed ID: 11015479 [TBL] [Abstract][Full Text] [Related]
9. MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients. Noiri E; Taguchi J; Nakao A; Fujita T Diabetes Care; 2000 Feb; 23(2):260. PubMed ID: 10868846 [No Abstract] [Full Text] [Related]
10. Total plasma homocysteine is associated with hypertension in Type I diabetic patients. Neugebauer S; Tarnow L; Stehouwer C; Teerlink T; Baba T; Watanabe T; Parving HH Diabetologia; 2002 Sep; 45(9):1315-24. PubMed ID: 12242465 [TBL] [Abstract][Full Text] [Related]
11. No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy. Fujita H; Narita T; Meguro H; Ishii T; Hanyu O; Suzuki K; Kamoi K; Ito S J Diabetes Complications; 1999; 13(5-6):284-7. PubMed ID: 10765003 [TBL] [Abstract][Full Text] [Related]
12. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients. El-Baz R; Settin A; Ismaeel A; Khaleel AA; Abbas T; Tolba W; Abd Allah W; Sobh MA J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):472-7. PubMed ID: 22554825 [TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese Type 2 diabetic patients. Yoshioka K; Yoshida T; Umekawa T; Kogure A; Takakura Y; Toda H; Yoshikawa T Diabet Med; 2004 Sep; 21(9):1051-2. PubMed ID: 15317615 [No Abstract] [Full Text] [Related]
14. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy]. Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582 [TBL] [Abstract][Full Text] [Related]
15. MTHFR gene variant is not associated with diabetic nephropathy in Japanese. Odawara M; Yamashita K; Yamada N Nucleic Acids Symp Ser; 1999; (42):85-6. PubMed ID: 10780391 [TBL] [Abstract][Full Text] [Related]
16. [Genetic risk factor for the onset and progression of diabetic complication]. Nakajima K; Tanaka Y Nihon Rinsho; 2002 Oct; 60 Suppl 10():95-101. PubMed ID: 12430213 [No Abstract] [Full Text] [Related]
17. Mutation C677T of methylenetetrahydrofolate reductase gene is not associated with coronary artery disease, but possibly with albuminuria, in type 2 diabetic patients. Wirta V; Huang XH; Wirta O; Rantalaiho V; Pasternack A; Jokela H; Koivula T; Lehtimäki T Clin Chem Lab Med; 1998 Aug; 36(8):625-8. PubMed ID: 9806473 [TBL] [Abstract][Full Text] [Related]
18. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM. Arai K; Yamasaki Y; Kajimoto Y; Watada H; Umayahara Y; Kodama M; Sakamoto K; Hori M Diabetes; 1997 Dec; 46(12):2102-4. PubMed ID: 9392503 [No Abstract] [Full Text] [Related]
19. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients. Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442 [TBL] [Abstract][Full Text] [Related]
20. The relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and diabetic nephropathy in Croatian type 2 diabetic patients. Tomić NG; Marusić S; Bozikov V; Kusec R; Bacić-Vrca V; Tadić M Coll Antropol; 2013 Sep; 37(3):789-93. PubMed ID: 24308218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]